RDash vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Indian construction management platform for design, procurement, and project finance; $5.59M from Stellaris Venture Partners at ₹75.3 Crore ($9M) ARR serving 250+ businesses managing ₹1000+ crore projects.
About
RDash is a Bengaluru-based construction management platform automating workflows for design, procurement, project tracking, and finance across interior design and construction projects — providing Indian contractors, interior designers, architects, and real estate developers with an integrated software platform that replaces the fragmented spreadsheets, WhatsApp groups, and manual processes that characterize Indian construction project management. RDash has raised $5.59 million including a $4.58 million seed round led by Stellaris Venture Partners, serves 250+ construction businesses managing 3,000+ projects worth over ₹1,000 crore, and achieved ₹75.3 crore ($9 million) in annual revenue as of March 2024.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.